Metabolite Identification Service

At Swiss BioQuant AG, we offer specialized metabolite identification (MetID) and structure elucidation services as part of our comprehensive bioanalytical solutions. Our expertise in drug development and regulated studies ensures that we provide precise and reliable results to support your pharmaceutical and biotechnology projects.

Our MetID services leverage high-resolution mass spectrometry (HRMS) to accurately identify and characterize drug metabolites. This advanced technology allows us to deliver detailed structural information and high-quality data, essential for understanding the metabolic pathways of your compounds. We offer both GLP-compliant and non-regulated (R&D) studies to cater to the diverse needs of our clients.

Key features of our MetID and structure elucidation services include:

• High-Resolution Mass Spectrometry: Utilizing state-of-the-art HRMS techniques (Sciex Zeno TOF 7600, Exploris 480) to provide accurate and detailed metabolite identification and structural elucidation.
• Collaborative Approach: Working closely with your team to provide customized solutions and expert guidance throughout the study.

Partner with Swiss BioQuant AG for your metabolite identification and structure elucidation needs and benefit from our commitment to excellence in bioanalytical services.

For more information, please contact us at mail@swissbioquant.com